Vaxcyte (PCVX) Earnings Analysis
Vaxcyte (PCVX) has no confirmed upcoming earnings date. Trailing P/E -8.13.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does PCVX next report earnings?
No confirmed upcoming earnings date is currently scheduled for PCVX. This page updates as the calendar is published.
PCVX earnings history — beats and misses
No reported earnings history is available for this symbol in our dataset.
PCVX valuation and analyst view
| Trailing P/E | -8.13 |
|---|---|
| Trailing EPS | -6.78485 USD |
| Price / book | 2.61 |
| Dividend yield | 0.00% |
| Market cap | 8.15B |
| Analyst consensus | Buy (11 buy / 0 hold / 0 sell) |
| Avg price target | 83 USD |
Related research pages
Frequently asked questions
When is Vaxcyte (PCVX)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for PCVX. This page updates as the calendar is published.
What is PCVX's current P/E ratio and EPS?
PCVX trades at a trailing P/E of -8.13 on trailing EPS of -6.784850732595744 USD.
What do analysts rate PCVX?
Analyst consensus is "Buy" across 11 ratings (0 strong buy, 11 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 83 USD.